Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Nonequilibrium Langevin dynamics: A demonstration study of shear flow fluctuations in a simple fluid.

Belousov R, Cohen EGD, Rondoni L.

Phys Rev E. 2017 Aug;96(2-1):022125. doi: 10.1103/PhysRevE.96.022125. Epub 2017 Aug 14.

PMID:
28950465
2.

Second-order fluctuation theory and time autocorrelation function for currents.

Belousov R, Cohen EG.

Phys Rev E. 2016 Dec;94(6-1):062124. doi: 10.1103/PhysRevE.94.062124. Epub 2016 Dec 19.

PMID:
28085350
3.

Langevin equation for systems with a preferred spatial direction.

Belousov R, Cohen EG, Rondoni L.

Phys Rev E. 2016 Sep;94(3-1):032127. Epub 2016 Sep 22.

PMID:
27739763
4.

Skewness of steady-state current fluctuations in nonequilibrium systems.

Belousov R, Cohen EG, Wong CS, Goree JA, Feng Y.

Phys Rev E. 2016 Apr;93:042125. doi: 10.1103/PhysRevE.93.042125. Epub 2016 Apr 21.

PMID:
27176272
5.

Poly (ADP) ribose polymerase inhibition: A potential treatment of malignant peripheral nerve sheath tumor.

Kivlin CM, Watson KL, Al Sannaa GA, Belousov R, Ingram DR, Huang KL, May CD, Bolshakov S, Landers SM, Kalam AA, Slopis JM, McCutcheon IE, Pollock RE, Lev D, Lazar AJ, Torres KE.

Cancer Biol Ther. 2016;17(2):129-38. doi: 10.1080/15384047.2015.1108486. Epub 2015 Dec 9.

6.

Heterogeneity and immunophenotypic plasticity of malignant cells in human liposarcomas.

Zhang Y, Young ED, Bill K, Belousov R, Peng T, Lazar AJ, Pollock RE, Simmons PJ, Lev D, Kolonin MG.

Stem Cell Res. 2013 Sep;11(2):772-81. doi: 10.1016/j.scr.2013.04.011. Epub 2013 May 12.

7.

Targeting the PI3K/mTOR axis, alone and in combination with autophagy blockade, for the treatment of malignant peripheral nerve sheath tumors.

Ghadimi MP, Lopez G, Torres KE, Belousov R, Young ED, Liu J, Brewer KJ, Hoffman A, Lusby K, Lazar AJ, Pollock RE, Lev D.

Mol Cancer Ther. 2012 Aug;11(8):1758-69. doi: 10.1158/1535-7163.MCT-12-0015. Epub 2012 Jul 30.

8.

Dual targeting of mTOR and aurora-A kinase for the treatment of uterine Leiomyosarcoma.

Brewer Savannah KJ, Demicco EG, Lusby K, Ghadimi MP, Belousov R, Young E, Zhang Y, Huang KL, Lazar AJ, Hunt KK, Pollock RE, Creighton CJ, Anderson ML, Lev D.

Clin Cancer Res. 2012 Sep 1;18(17):4633-45. doi: 10.1158/1078-0432.CCR-12-0436. Epub 2012 Jul 20.

9.

Survivin is a viable target for the treatment of malignant peripheral nerve sheath tumors.

Ghadimi MP, Young ED, Belousov R, Zhang Y, Lopez G, Lusby K, Kivlin C, Demicco EG, Creighton CJ, Lazar AJ, Pollock RE, Lev D.

Clin Cancer Res. 2012 May 1;18(9):2545-57. doi: 10.1158/1078-0432.CCR-11-2592. Epub 2012 Mar 8.

10.

Combining EGFR and mTOR blockade for the treatment of epithelioid sarcoma.

Xie X, Ghadimi MP, Young ED, Belousov R, Zhu QS, Liu J, Lopez G, Colombo C, Peng T, Reynoso D, Hornick JL, Lazar AJ, Lev D.

Clin Cancer Res. 2011 Sep 15;17(18):5901-12. doi: 10.1158/1078-0432.CCR-11-0660. Epub 2011 Aug 5.

11.

Activated MET is a molecular prognosticator and potential therapeutic target for malignant peripheral nerve sheath tumors.

Torres KE, Zhu QS, Bill K, Lopez G, Ghadimi MP, Xie X, Young ED, Liu J, Nguyen T, Bolshakov S, Belousov R, Wang S, Lahat G, Liu J, Hernandez B, Lazar AJ, Lev D.

Clin Cancer Res. 2011 Jun 15;17(12):3943-55. doi: 10.1158/1078-0432.CCR-11-0193. Epub 2011 May 3.

12.

Epithelioid sarcoma and unclassified sarcoma with epithelioid features: clinicopathological variables, molecular markers, and a new experimental model.

Sakharpe A, Lahat G, Gulamhusein T, Liu P, Bolshakov S, Nguyen T, Zhang P, Belousov R, Young E, Xie X, Rao P, Hornick JL, Lazar AJ, Pollock RE, Lev D.

Oncologist. 2011;16(4):512-22. doi: 10.1634/theoncologist.2010-0174. Epub 2011 Feb 28.

13.

Autophagic survival in resistance to histone deacetylase inhibitors: novel strategies to treat malignant peripheral nerve sheath tumors.

Lopez G, Torres K, Liu J, Hernandez B, Young E, Belousov R, Bolshakov S, Lazar AJ, Slopis JM, McCutcheon IE, McConkey D, Lev D.

Cancer Res. 2011 Jan 1;71(1):185-96. doi: 10.1158/0008-5472.CAN-10-2799. Epub 2010 Nov 16. Erratum in: Cancer Res. 2015 Apr 15;75(8):1771-4.

14.

An experimental model for the study of well-differentiated and dedifferentiated liposarcoma; deregulation of targetable tyrosine kinase receptors.

Peng T, Zhang P, Liu J, Nguyen T, Bolshakov S, Belousov R, Young ED, Wang X, Brewer K, López-Terrada DH, Oliveira AM, Lazar AJ, Lev D.

Lab Invest. 2011 Mar;91(3):392-403. doi: 10.1038/labinvest.2010.185. Epub 2010 Nov 8.

15.

Vimentin is a novel AKT1 target mediating motility and invasion.

Zhu QS, Rosenblatt K, Huang KL, Lahat G, Brobey R, Bolshakov S, Nguyen T, Ding Z, Belousov R, Bill K, Luo X, Lazar A, Dicker A, Mills GB, Hung MC, Lev D.

Oncogene. 2011 Jan 27;30(4):457-70. doi: 10.1038/onc.2010.421. Epub 2010 Sep 20.

16.

[Proton transfer via the external proton channel of bacteriorhodopsin].

Belousov RV, Kukushkin AK.

Biofizika. 2006 Jul-Aug;51(4):704-9. Russian.

PMID:
16909850
17.

[The submolecular mechanism of the initial stage of the electron coupling in the water oxidizing center of higher plants].

Belousov RV, Belov AA, Kukushkin AK.

Biofizika. 2004 May-Jun;49(3):486-92. Russian.

PMID:
15327207
18.

A theoretical model for electron and proton coupling at quinone-binding site of photosystem II of higher plants.

Belousov RV, Poltev SV, Kukushkin AK.

Bioelectrochemistry. 2004 Jun;63(1-2):95-8.

PMID:
15110255
19.

Supplemental Content

Loading ...
Support Center